ArticleCancer letters2013

A novel antitumor activity of deguelin targeting the insulin-like growth factor (IGF) receptor pathway via up-regulation of IGF-binding protein-3 expression in breast cancer.

Young-Ah Suh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.